The Latest Breaking News from CVS Health Corporation

The largest U.S. drugstore chain, CVS Health (CVS), will release its fourth-quarter results on February 7. The company is expected to report year-over-year growth in revenue and earnings. With the expected rise in medical costs during the fourth quarter, should investors consider buying the stock now? Read on to learn…

The healthcare industry harbors a robust stance capable of withstanding various market challenges, thanks to the ceaseless requisite for its services. This is entwined with an escalating demand for healthcare facilities, pharmaceutical solutions, and pioneering medical breakthroughs, laying a robust foundation for the industry's continued prosperity. Given this backdrop, fundamentally…

The medical sector is expected to grow amid steady demand and technological advancements. So, let's analyze which of these stocks, CVS Health (CVS), Walgreens Boots Alliance (WBA), and TRxADE HEALTH (MEDS), has the better growth opportunities.

The healthcare industry is expected to see increased M&A activity this year, fueled by ample cash reserves and private equity dry powder. Investors could take advantage of this trend by investing in fundamentally sound healthcare stocks UnitedHealth (UNH), Elevance Health (ELV), and CVS Health (CVS). Continue reading….

High inflation and stock market volatility necessitate adding a defensive layer to your portfolio to save yourself from exhausting all your savings. Hence, one could consider planning their retirement with quality stocks Oracle Corp. (ORCL), CVS Health (CVS), and Humana (HUM), given their strong fundamentals and steady returns. Read on….

The bank failures and the Fed’s monetary tightening have increased the risk of a recession later this year. This is expected to keep the stock market under pressure. Amid this uncertainty, it could be wise to buy and hold fundamentally strong stocks Oracle (ORCL), CVS Health (CVS), and Humana (HUM)…

The recent banking turmoil caused by high-profile bank failures, renewed recession fears, and uncertainty over the Fed’s next move have significantly affected investor sentiment. Amid an uncertain market backdrop, it could be wise to buy and hold fundamentally sound, dividend-paying stocks Oracle Corporation (ORCL), CVS Health (CVS), and Humana (HUM)…

With the stock market anticipated to stay volatile due to persistent concerns about high inflation, interest rate hikes, and a recession, fundamentally solid dividend stocks Gilead Sciences (GILD), CVS Health (CVS), and Altria (MO) might be great buys for a steady income stream. Keep reading.

The medical industry is expected to grow due to robust demand and government support. Therefore, investors could consider buying fundamentally strong medical stocks, UnitedHealth Group (UNH), Nature's Sunshine Products (NATR), and CVS Health (CVS), for the long term. Keep reading.